MC4R-selective agonist. FDA approved for hypoactive sexual desire disorder in premenopausal women.
● Issue Jul 2026
Glossary
SYSTEMM · 1 min read
07·01·2026
PT-141 (Bremelanotide)
MC4R-selective agonist. FDA approved for hypoactive sexual desire disorder in premenopausal women.